22157.jpg
Global Oncolytic Virus Therapy Market Report 2023: Increase in Clinical Trials and Approval of New Virus Therapies Boosts Growth
May 11, 2023 07:33 ET | Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook to 2035" report has been added to ResearchAndMarkets.com's offering.The global oncolytic virus therapy...
22157.jpg
Insights on the Oncolytic Virus Immunotherapy Global Market to 2028 - Featuring Key Players AdCure Bio, BioVex, Calidi Biotherapeutics, Takara Bio and Others
December 13, 2022 06:08 ET | Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market and Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The global...
Global T-Cell Immunotherapy Market
Global T-Cell Immunotherapy Market Report to 2027 - Featuring Atara Biotherapeutics, Autolus and bluebird bio Among Others
July 21, 2022 07:18 ET | Research and Markets
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Research Nester  Logo
Global Oncolytic Virus Therapy Market to Touch a Revenue of USD 1062.7 Million by 2028; Increasing Investments for Cancer Research and Rising Incidences of Cancer to Accelerate Market Growth
December 07, 2021 07:17 ET | Research Nester
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the World Health Organization (WHO), cancer-related deaths recorded close to 10 Million in the year 2020. Moreover, amongst...
22157.jpg
Global $1060 Million Oncolytic Virus Therapy Markets Outlook 2021-2028 by Therapy Type, Virus Type, Indication, Demography, End-user
December 01, 2021 05:08 ET | Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market is anticipated to garner a...
22157.jpg
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
22157.jpg
TIL-based Therapies Market by Target Indications, Key Players and Key Geographies - Global Industry Trends and Forecasts, 2021-2030
July 23, 2021 04:13 ET | Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "TIL-based Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030" report has been...
22157.jpg
TCR-based Therapies Market Research Report 2021
July 16, 2021 04:58 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
22157.jpg
Global Oncolytic Virus Therapies Market Report 2021-2030: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, and Competitive Landscape
April 22, 2021 06:38 ET | Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and...
Emergen logo.png
Oncolytic Virus Therapy Market Size to Reach USD 866.1 Million by 2028 | Growing Awareness About Early Cancer Detection is a Significant Factor Driving Industry Growth, says Emergen Research
February 23, 2021 09:08 ET | Emergen Research
Vancouver, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to...